Phenylalanylalanine

CAS No. 3918-87-4

Phenylalanylalanine( H-Phe-Ala-OH )

Catalog No. M28304 CAS No. 3918-87-4

Phenylalanylalanine (H-Phe-Ala-OH) is a dipeptide composed of phenylalanine and alanine. Phenylalanylalanine is an incomplete breakdown product of protein digestion or protein catabolism.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG Get Quote In Stock
200MG 27 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Phenylalanylalanine
  • Note
    Research use only, not for human use.
  • Brief Description
    Phenylalanylalanine (H-Phe-Ala-OH) is a dipeptide composed of phenylalanine and alanine. Phenylalanylalanine is an incomplete breakdown product of protein digestion or protein catabolism.
  • Description
    Phenylalanylalanine (H-Phe-Ala-OH) is a dipeptide composed of phenylalanine and alanine. Phenylalanylalanine is an incomplete breakdown product of protein digestion or protein catabolism.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    H-Phe-Ala-OH
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Tyrosinase|Calcium Channel|Antifection|Antibacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    3918-87-4
  • Formula Weight
    236.271
  • Molecular Formula
    C12H16N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?H2O : 100 mg/mL (423.24 mM)
  • SMILES
    C[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ruddock PS, et al. Antimicrobial activity of flavonoids from Piper lanceaefolium and other Colombian medicinal plants against antibiotic susceptible and resistant strains of Neisseria gonorrhoeae. Sex Transm Dis. 2011 Feb;38(2):82-8.
molnova catalog
related products
  • Probucol disuccinate

    Probucol is an anti-hyperlipidemic drug initially developed in the treatment of coronary artery disease by lowering the level of cholesterol in the bloodstream by increasing the rate of LDL catabolism.

  • NRX-1933

    NRX-1933 is a molecular glue and enhances the interaction between an oncogenic transcription factor, β-Catenin, and its cognate E3 ligase, SCFβ-TrCP.

  • WWL229

    WWL229 is a selective inhibitor of Ces3.